Chemistry:Verducatib

From HandWiki

Verducatib is an investigational new drug that is being evaluated by Boehringer Ingelheim for the treatment of bronchiectasis.[1] It is a cathepsin C inhibitor.[1][2]

References

  1. ↑ 1.0 1.1 "Verducatib". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800051229. 
  2. ↑ "Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A Podcast". Pulmonary Therapy 12 (1): 1–12. March 2026. doi:10.1007/s41030-025-00330-1. PMID 41269659. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Verducatib&oldid=4582798"